A new trading day began on Friday, with VolitionRX Ltd (AMEX: VNRX) stock price up 7.94% from the previous day of trading, before settling in for the closing price of $0.64. VNRX’s price has ranged from $0.40 to $0.94 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 5.38% over the past five years. Meanwhile, its annual earnings per share averaged 50.32%. With a float of $79.07 million, this company’s outstanding shares have now reached $103.98 million.
Let’s look at the performance matrix of the company that is accounted for 85 employees. In terms of profitability, gross margin is 100.0%, operating margin of -1846.74%, and the pretax margin is -1854.43%.
VolitionRX Ltd (VNRX) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Medical Devices Industry. The insider ownership of VolitionRX Ltd is 26.51%, while institutional ownership is 23.07%. The most recent insider transaction that took place on Aug 05 ’25, was worth 50,000. In this transaction Director of this company bought 78,125 shares at a rate of $0.64, taking the stock ownership to the 966,814 shares. Before that another transaction happened on Aug 05 ’25, when Company’s President and CEO bought 78,125 for $0.64, making the entire transaction worth $50,000. This insider now owns 2,609,847 shares in total.
VolitionRX Ltd (VNRX) Latest Financial update
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.07 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 50.32% per share during the next fiscal year.
VolitionRX Ltd (AMEX: VNRX) Trading Performance Indicators
Here are VolitionRX Ltd’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 0.35. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 56.64.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.24, a number that is poised to hit -0.05 in the next quarter and is forecasted to reach -0.07 in one year’s time.
Technical Analysis of VolitionRX Ltd (VNRX)
VolitionRX Ltd (AMEX: VNRX) saw its 5-day average volume 0.27 million, a positive change from its year-to-date volume of 0.2 million. As of the previous 9 days, the stock’s Stochastic %D was 46.99%.
During the past 100 days, VolitionRX Ltd’s (VNRX) raw stochastic average was set at 55.02%, which indicates a significant decrease from 61.23% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0516 in the past 14 days, which was lower than the 0.0592 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6891, while its 200-day Moving Average is $0.6081. Nevertheless, the first resistance level for the watch stands at $0.7599 in the near term. At $0.8250, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8949. If the price goes on to break the first support level at $0.6249, it is likely to go to the next support level at $0.5550. The third support level lies at $0.4899 if the price breaches the second support level.
VolitionRX Ltd (AMEX: VNRX) Key Stats
With a market capitalization of 74.77 million, the company has a total of 103,982K Shares Outstanding. Currently, annual sales are 1,230 K while annual income is -26,970 K. The company’s previous quarter sales were 250 K while its latest quarter income was -5,420 K.
